TABLE 2

Respondent Characteristics (N = 37)

Characteristicn%
Gender
    Male1643
    Female2157
Age, ya
    Boys, <14822
    Boys, >14822
    Girls, <14924
    Girls, >141232
Cancer diagnosis
    ALL1130
    AML38
    CNS822
    HD616
    NHL38
    GCT38
    Osteosarcoma25
    Ewing13
Research protocol
    Pilot25
    Phase I13
    Phase I/II13
    Phase II616
    Phase III2670
    Biology (tissue sample)13
Months since protocol enrollment
    <41130
    4–12719
    12–241438
    >24513
Treatment
    Ongoing2362
    Completed1438
  • a Respondents were aged 7 to 18 years at the time of cancer diagnosis. Some interviews took place months after diagnosis; therefore, 3 respondents, 2 aged 17 years and 1 aged 18 years at diagnosis, were 19 years old at the time interviews occurred. ALL indicates acute lymphoblastic leukemia; AML, acute myelogenous leukemia; CNS, central nervous system; NHL, non-Hodgkin's lymphoma.